Sarah Cavanaugh

Business address
C/O Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ, 08827
Top holdings (ownership)
CLDX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Sarah Cavanaugh has filed 16 SEC EDGAR filings since 16 Jun 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 09 Jun 2025 05 Jun 2025 000-15006
4 Open Document Open Filing 17 Jun 2024 13 Jun 2024 000-15006
4 Open Document Open Filing 03 Jun 2024 30 May 2024 000-15006
144 Open Document Open Filing 30 May 2024
4 Open Document Open Filing 20 Jun 2023 15 Jun 2023 000-15006
4 Open Document Open Filing 19 Aug 2022 17 Aug 2022 000-15006
4 Open Document Open Filing 17 Jun 2022 16 Jun 2022 000-15006
4 Open Document Open Filing FORM 4 - 10 Dec 2021 08 Dec 2021 000-15006
4 Open Document Open Filing FORM 4 - 03 Nov 2021 01 Nov 2021 000-15006
4 Open Document Open Filing FORM 4 - 21 Jun 2021 17 Jun 2021 000-15006
4 Open Document Open Filing FORM 4 - 19 Jun 2020 18 Jun 2020 000-15006
4 Open Document Open Filing FORM 4 - 11 Jun 2020 10 Jun 2020 000-15006
4 Open Document Open Filing FORM 4 - 20 Jun 2019 19 Jun 2019 000-15006
4 Open Document Open Filing FORM 4 - 15 Jun 2018 13 Jun 2018 000-15006
4 Open Document Open Filing FORM 4 - 16 Jun 2017 15 Jun 2017 000-15006
3 Open Document Open Filing OWNERSHIP DOCUMENT 16 Jun 2017 15 Jun 2017 000-15006